GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology
description
Transcript of GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology
![Page 1: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/1.jpg)
GENNEREGeneric and Epidemiological Network for Nephrology and
RheumatologyP. Gaudin*, Hao Ping*, ++, F. Raguimov++, M. Simonet++, A. Simonet++, M. Forêt***,
P. Landais+, Dr D. Guillon***
Rheum. Dpt*, AGDUC***, CHU A. Michallon Grenoble,Lab. TIMC++, UJFLBIM University Necker Paris+
![Page 2: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/2.jpg)
Aspects épidémiologiques
Polyarthrite rhumatoïde (PR) Rheumatoid arthritis (RA)
Prévalence : 0.5% population caucasienne Incidence : 40/100 000 habitants Arthrite juvénile idiopathique 15 ans et 3 mois : PR Espérance de vie diminuée, morbidité CV +++ Sex ratio : 4F/1H Pic de fréquence : 40-50 ans Étiologie multifactorielle
![Page 3: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/3.jpg)
Aspects médico-économiques
15% de formes graves 50% arrêt activité prof. à 5 ans 10% invalidité III en 2 ans 25% temps aménagé coûts directs : traitements, hospitalisations… coûts indirects : arrêts travail, prestations
sociales coûts intangibles : douleur, anxiété,
déformations, QDV
![Page 4: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/4.jpg)
Economic Burden in Europe
In West Germany, RA costs were >DM 40 billion (US $17.6 billion) in 1994 for treatment alone
In the UK, average RA outpatient cost per case per year was £798 (US $1,126) and £1,253 (US $1,769) per inpatient in 1997
Rheumatoid arthritis per capita costs average: 49% of cost of cancer 68% of cost of stroke 82% of cost of coronary heart disease 5 times the cost of motor vehicle accidents
Knorr U. Versicherungsmedizin 1994.Rothfuss J. Akt Rheumatol 1997.Lubeck DP, et al. Arthritis Rheum 1986;29:488–493.Lorig KR, et al. Arthritis Rheum 1993;36:439–446.
![Page 5: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/5.jpg)
Indirect Productivity Costs of RASweden: 37% retired early after
the first 2 years of RAFinland: 64% retired after 8 yearsThe Netherlands: 60% were not
employed 73% full disability from RA 21% partial disability from RA
![Page 6: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/6.jpg)
Risk Factors for Increased Morbidity and Mortality in RA
Social factors Low socioeconomic status Lack of formal education Psychosocial stress Low HAQ scores
Physical factors Extra-articular manifestations Elevated CRP and ESR High titers of RF Erosions on x-ray Duration of disease
Bukhari M, et al. Arthritis Rheum 2002;46:906-912.
![Page 7: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/7.jpg)
Ag
+AGENTETIOLOGIQUE
(AUTO)IMMUNITE
AMPLIFICATION
MEDIATEURS MALADIE
CPA
LT
![Page 8: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/8.jpg)
![Page 9: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/9.jpg)
![Page 10: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/10.jpg)
Int. J. Rheumatol. 2003;1,2-9
![Page 11: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/11.jpg)
Goals GENNERE I Tool for the follow up of RA patients Focused on epidemiological data Extension possible to SLE, AS Tool made with and by chinese partners Connexion between different hospitals in
Shanghai first
GENNERE II Data ware house Connexion between different cities
![Page 12: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/12.jpg)
Workplan-Kickoff meeting April 2003 Study and choice of software tools Extension and adaptation of generic tools Analysis of users requirements Database design Database validation Software design Training of chinese partners Software validation Database implementation
![Page 13: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/13.jpg)
![Page 14: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/14.jpg)
![Page 15: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/15.jpg)
![Page 16: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/16.jpg)
![Page 17: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/17.jpg)
![Page 18: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/18.jpg)
![Page 19: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/19.jpg)
![Page 20: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/20.jpg)
![Page 21: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/21.jpg)
![Page 22: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/22.jpg)
![Page 23: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/23.jpg)
![Page 24: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/24.jpg)
![Page 25: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/25.jpg)
![Page 26: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/26.jpg)
![Page 27: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/27.jpg)
![Page 28: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/28.jpg)
![Page 29: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/29.jpg)
![Page 30: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/30.jpg)
![Page 31: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/31.jpg)
![Page 32: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/32.jpg)
![Page 33: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/33.jpg)
![Page 34: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/34.jpg)
![Page 35: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/35.jpg)
![Page 36: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/36.jpg)
![Page 37: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/37.jpg)
![Page 38: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/38.jpg)
![Page 39: GENNERE G eneric and E pidemiological N etwork for N ephrology and R h e umatology](https://reader035.fdocuments.in/reader035/viewer/2022062810/56815b85550346895dc98888/html5/thumbnails/39.jpg)
GENNERE I II nPatient 1Patient 2Patient 3…………Patient n
TO TxLongitudinal and transversal studies + data ware house +++Limites : épidemiologiste, besoins, adaptations